According to ChemoCentryx's latest financial reports the company's current revenue (TTM) is $37.2 M. In 2021 the company made a revenue of $31.9 M a decrease over the years 2020 revenue that were of $64.39 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2022 (TTM) | $37.2 M | 16.61% |
2021 | $31.9 M | -50.46% |
2020 | $64.39 M | 79.11% |
2019 | $35.95 M | -16.15% |
2018 | $42.87 M | -48.03% |
2017 | $82.49 M | 621.44% |
2016 | $11.43 M | |
2015 | N/A | |
2014 | N/A | -100% |
2013 | $6.06 M | 11.83% |
2012 | $5.41 M | -82.89% |
2011 | $31.67 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $89.65 B | 240,918.82% | ๐บ๐ธ USA |
Pfizer PFE | $58.49 B | 157,150.00% | ๐บ๐ธ USA |
AbbVie ABBV | $54.31 B | 145,916.13% | ๐บ๐ธ USA |
Amgen AMGN | $28.19 B | 75,679.57% | ๐บ๐ธ USA |
Biogen BIIB | $9.66 B | 25,876.08% | ๐บ๐ธ USA |
Merck MRK | $60.11 B | 161,496.77% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $45.53 B | 122,303.23% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $38.54 B | 103,511.49% | ๐ฌ๐ง UK |
Teva Pharmaceutical Industries TEVA | $15.84 B | 42,496.77% | ๐ฎ๐ฑ Israel |